Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:drug |
| gptkbp:CASNumber |
136314-34-6
|
| gptkbp:developedBy |
gptkb:Merck
|
| gptkbp:hasMolecularFormula |
C27H28N4O3S
|
| gptkbp:hasSMILES |
COC1=C(C=C(C=C1)C(C(C2=NN=CN2)NC(=O)N3CCC(C3)CC4=CC=CC=C4)O)OC
|
| gptkbp:hasUNII |
1Q7V2V5F1E
|
| gptkbp:heldBy |
cholecystokinin-B receptor antagonist
|
| https://www.w3.org/2000/01/rdf-schema#label |
L-365,260
|
| gptkbp:is_not_approved_for_clinical_use |
true
|
| gptkbp:IUPACName |
(2R,3S)-N-[(2S)-1-Benzyl-2-(hydroxymethyl)pyrrolidin-2-yl]-2-(3,4-dimethoxyphenyl)-3-(1H-1,2,4-triazol-1-yl)propanamide
|
| gptkbp:PubChem_CID |
107970
CHEMBL27356 |
| gptkbp:target |
gptkb:CCK-B_receptor
|
| gptkbp:used_in_research_for |
pain
anxiety gastrointestinal disorders |
| gptkbp:bfsParent |
gptkb:CCK-B_receptor
|
| gptkbp:bfsLayer |
7
|